Back to Agenda
Session 8 Track 1: From Responsible AI to Scientific Visibility: Transforming Medical Information and Maximizing Content Impact
Session Chair(s)
Marta Avellar, MBA
Head, Global Medical Information Operational Excellence, Compliance and GCM, Takeda, Brazil
Session 8 Track 1: From Responsible AI to Scientific Visibility: Transforming Medical Information and Maximizing Content Impact
Learning Objective : Assess the risks associated with AI development and regulatory gaps Apply ethical principles when implementing an AI-driven process in Medical Information Validation of AI solutions to stay compliant
Speaker(s)
Ethical and Responsible Use of AI in Medical Information
Rajul Jain, MBA
President, Medical Information, ProPharma, United States
Building a Medical Information AI Assistant with Existing Tools: A Practical Alternative to Vendor Platforms
Katie Moy, PharmD
Associate Director, Medical Information & Review, Acadia Pharmaceuticals, United States
Is AI Citing Your Science? Answer Engine Optimization for Medical Publications and Content
Manu Kadyan, MBA, MS
Manager, Pwc, United States
Have an account?